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Abstract
Gene therapy has many uses today through the new
treatment options and it’s potential to treat uncurable
diseases

Introduction
•Utilizing genes, DNA or RNA components, to treat
conditions rather than pharmaceutical drugs.
•Helps with synthesis of functional proteins which could be
missing, faulty, or mutated due to the condition
•Two types of gene therapy: somatic and germline
•Two modes of delivery: in vivo and ex vivo

Examples

Discussion

Table 1: FDA/EMA approved gene therapy products [5]

Gene therapy is heavily tested to make sure the
safety and effectiveness of the therapy
Currently many gene therapies released and
approved by FDA, or similar, approved
Some challenges are primarily due to the types
of viral vectors leading to cancer or nonspecific
binding.
The future of gene therapy reaches into
possible repairing of damaged tissues and
alternative cancer treatments

Name

Year

Agency

Indication

Yescarta

2017

FDA

Lymphoma

Kymiah

2017

FDA

Leukemia

Strimvelis

2016

EMA

ADA-SCID

Conclusion

Novelty of Work
•Less side effects, less chances of rejection
•Allows treatments for non-treatable diseases

Methodology
Vectors are modes to transfer the genes inside targeted
cells and are used to protect and incase the gene
Types of Vectors:
•Plasmid – circular DNA molecules
•Viral – modified viruses
Vectors containing corrected DNA/RNA can be inserted
directly into the patient or ex vivo
One way vector can be inserted is through intravenous
Patient cells can be removed and exposed to vector
before intravenous insertion

Figure 1: Demonstration of ex vivo and in vivo
approaches [2]

Despite the drawbacks, gene therapy could be the
answer to many genetic disorders being treated or
even eradicated
With obvious challenges, gene therapy could be the
only option for treating several genetic and chronic
conditions (Cancer)
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